Bookmark
Forward
The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
Seminars in immunopathology 2017 FebSizes of these terms reflect their relevance to your search.
In this review, we focus on the biologic advantages of dendritic cell-based vaccinations as a therapeutic strategy for cancer as well as preclinical and emerging clinical data associated with such approaches for glioblastoma patients.
Citation
David A Reardon, Duane A Mitchell. The development of dendritic cell vaccine-based immunotherapies for glioblastoma. Seminars in immunopathology. 2017 Feb;39(2):225-239
Mesh Tags
Substances
PMID: 28138787
View Full Text
